I see that DRL is claiming a 36% total market share for November; up from 33% in August. Perhaps inconsistent with last ACL update, which indicated a 30% market share for 3 months ending September 30. And, as we know, increasing market share doesn't necessarily translate to increasing profits.
But, hopefully a positive trend, that combined with process improvements could/should see an improved ACL return for last quarter. At least back to the $3 million received for June qtr; and hopefully more.
I realise that oncology is the big opportunity for ACL going forward. But having a decent revenue stream from fonda is sure a bonus for a biotech.
- Forums
- ASX - By Stock
- TSN
- reddys fonda market share
reddys fonda market share
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable